BioCentury
ARTICLE | Clinical News

Regulus preclinical data

April 21, 2014 7:00 AM UTC

In a mouse xenograft model of HCC, thrice-weekly subcutaneous 25 mg/kg anti-microRNA-221 (miR-221) oligonucleotides for 3 weeks significantly inhibited tumor growth vs. vehicle-treated controls (p<0.0...